PT Itama Ranoraya Tbk

Jakarta Stock Exchange IRRA.JK

PT Itama Ranoraya Tbk Operating Cash Flow for the year ending December 31, 2023: USD -2.45 M

PT Itama Ranoraya Tbk Operating Cash Flow is USD -2.45 M for the year ending December 31, 2023, a -168.73% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

PT Itama Ranoraya Tbk Operating Cash Flow for the year ending December 31, 2022 was USD 3.56 M, a 147.59% change year over year.
PT Itama Ranoraya Tbk Operating Cash Flow for the year ending December 31, 2021 was USD -7.48 M, a -172.63% change year over year.
PT Itama Ranoraya Tbk Operating Cash Flow for the year ending December 31, 2020 was USD 10.30 M, a 1,848.08% change year over year.
PT Itama Ranoraya Tbk Operating Cash Flow for the year ending December 31, 2019 was USD -589.00 K, a 7.67% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Jakarta Stock Exchange: IRRA.JK

PT Itama Ranoraya Tbk

CEO	Mr. Heru Firdausi Syarif
IPO Date	Oct. 15, 2019
Location	Indonesia
Headquarters	MT. Haryono Square
Employees	229
Sector	Consumers Staples
Industries Personal Care Baby & Childcare Cleaning Supplies Consumer Packaged Goods Cosmetics Dental Care Medical Instruments Plastics

Description

PT Itama Ranoraya Tbk engages in the procurement of health goods in Indonesia. It offers non-electromedical sterile medical devices, in vitro diagnostic products, and other products. The company's products include ADS syringes, blood screening machines and reagents, apheresis machines, blood processing machines, rapid test products, vaccine refrigerators, masks, products for surgery in hospitals, ultrasound, and health supplements. It is also involved in building and office space rental business. The company was founded in 1988 and is headquartered in Jakarta Timur, Indonesia. PT Itama Ranoraya Tbk is a subsidiary of PT Global Dinamika Kencana.

Key trends

Past 5 years